Company ProfilePremium

HMC Capital Limited

Company Profile Analysis

Ticker: HMC.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
HMC Capital Limited - Company showcase

Year Founded & Workforce

2016

70 Employees

HMC Capital Limited logo

HMC Capital Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

HMC Capital Limited Overview

HMC Capital is an ASX-listed diversified alternative asset manager that originated as a property owner — the vehicle that bought and repurposed the former Masters Home Improvement portfolio — and evolved into a multi-platform manager across real estate, private credit, digital infrastructure and energy, with private equity now wound down. It manages roughly $18.6bn of AUM (FY26, excluding US Stratcap) and $16.9bn of fee-generating AUM for institutional, high-net-worth and retail investors. Its model is "seed, scale, syndicate": use the balance sheet to originate large, complex transactions, then transfer assets into listed REITs (HomeCo Daily Needs REIT, HealthCo Healthcare & Wellness REIT, DigiCo Infrastructure REIT) and unlisted funds that pay recurring fees, while HMC keeps material co-investments. After an extraordinary 2019–2024 growth phase and a share price collapse of more than 75% from its November 2024 peak, the group spent FY26 simplifying: exiting US digital operations, closing HMCCP, bringing KKR into its energy platform and adding institutional credit mandates.


Company's own description (paraphrased from FY26 Annual Report)

HMC Capital describes its principal activity as funds management through owning and managing real-asset funds exposed to high-conviction global megatrends. Its stated objective is to deliver above-average risk-adjusted returns to shareholders. It does this by investing in scalable real-asset strategies alongside third-party capital in HMC-managed funds, while maintaining an appropriate capital structure. In its boilerplate "About" text, the company says its point of difference is the ability to execute large, complex transactions, which it credits for rapid FUM growth (FY26 Results Announcement).

Independent characterisation

HMC is best understood as a hybrid between a fee-earning alternative asset manager and a listed principal investor:

  1. Fee engine (asset-light). Base management fees from listed REITs (HDN, HCW, DGT), unlisted real estate funds (HARP, HUG, LML Fund, Unlisted Healthcare Fund), private credit funds and mandates (Payton-originated CRE lending), and Illuma Energy. Recurring funds management revenue was $165.5m in FY26, up 22% (FY26 Results Announcement).

  2. Transaction and performance fees (episodic). Acquisition, development and capital-raising fees, plus performance fees. FY25 included a $24.7m HMCCP performance fee, $59.1m of DGT-related fees and $1.7m in Real Estate. FY26 included a $35m energy transaction fee tied to the KKR partnership.

  3. Principal investments (balance-sheet heavy). About $1.4bn of balance-sheet investments, chiefly co-investment stakes in HDN (10.5%), HCW (22.7%), DGT (20.7%) and Illuma Energy (~$200m remaining), plus retained listed equities from the former HMCCP portfolio. These produce distributions, realised gains and — under fair-value and equity accounting — large swings in statutory profit.

Revenue model mix

Revenue typeDescriptionFY26 indicator
Base management fees (recurring)% of AUM or GAV in listed and unlisted vehiclesRecurring FM revenue $165.5m (FY26)
Transaction / acquisition / development feesCharged on deployment, developments and capital events$35m energy fee (FY26)
Performance feesHurdle-based, mainly HMCCP historicallyNil in FY26 vs $24.7m in FY25
Investment incomeDistributions, dividends, realised and unrealised gains on co-investmentsShare of associate distributions $32.9m; dividend income $15.2m; fair value loss $(133.3)m
Corporate services feesServices to managed platforms$5m p.a. from Illuma Energy (Kalkine, 6 Feb 2026)

There are no product sales, licensing or subscription revenues in the conventional sense. Using FY26 continuing revenue of $181.9m, the business is effectively ~100% services, of which about 90% is recurring management fees once the $35m one-off energy fee is excluded (derived).

Value chain position, customers and end-markets

Value chain: sponsor → originator/acquirer → developer → fund manager → asset manager. HMC sits at the top of the chain as sponsor and capital allocator, outsourcing most property operations to tenants and service providers.

Customer types (capital providers): ASX retail and institutional securityholders of the listed REITs; wholesale and high-net-worth investors (private credit funds, formerly HMCCP); global institutions (KKR in energy; TPG Credit and other global institutional mandates in private credit).

End-markets (asset users): convenience/daily-needs and large-format retail tenants (HDN); healthcare operators including hospital operators (HCW / UHF); data centre customers including hyperscale and enterprise users (DGT); electricity off-takers and the market operator via Capacity Investment Scheme contracts (Illuma); commercial real estate borrowers (Private Credit).

Strategy

Stated strategy (paraphrased themes from the FY26 Annual Report and Results)

  1. Simplify, scale, strengthen. FY26 was framed as a year of execution: narrowing the business, scaling institutional partnerships and rebuilding balance sheet capacity.

  2. Seed–scale–syndicate. Use the balance sheet to acquire or originate undervalued real assets, then syndicate them to third-party capital and retain co-investments (FY26 Presentation).

  3. Focus on high-ROE Australian platforms. The priorities are Real Estate, Private Credit, Digital Infrastructure (via DGT, refocused on Australia) and Energy (via Illuma, now capital-light).

  4. Institutionalisation. The aim is to attract long-dated global institutional capital, as with KKR and TPG Credit.

  5. Recurring earnings and cash conversion. Underlying EPS is the new key metric, with 100% cash conversion targeted in FY27.

Initiatives announced in the last 24 months

DateInitiativeDetail / target
Nov 2024$50bn+ AUM and 20% ROE ambition (3–5 years)Reiterated through 2025; the DGT-specific aspiration of $50bn was scaled back by Sep 2025 (Kalkine)
2H FY25Launch of HARP and HUGTargeting up to $2bn of AUM
Aug 2025Private Credit Core Fund raisingWholesale channel expansion
Aug 2025FY26 targets≥40c OE; Real Estate FM EBITDA +15%; Private Credit FM EBITDA +20%; nil permanent core debt
Feb 2026KKR energy partnershipUp to $603m; deconsolidation; $35m fee
May 2026Group restructureHMCCP closure; StratCap wind-down; support function integration; DGT US asset sales
Jun 2026Private credit mandates$1.35bn, including the TPG Credit partnership (>$1bn of institutional capital)
FY26Cost programmeSavings from simplification support FY27 guidance (quantum n/d)
FY26–FY27Sustainability strategy refreshTo align with the Digital and Illuma platforms; AASB S2 climate reporting mandatory from FY27

Medium-term guidance

MetricFY27 guidance
Underlying EPS, pre-tax (AUD cents)≥35.0 (+16% vs 30.2c)
DPS (AUD cents)15.0 (+25%)
Recurring FM revenue growth (%)>30
Co-investment distribution growth (%)~35
Cash conversion of underlying earnings (%)100

Guidance excludes upside from recycling capital out of the $1.4bn of balance-sheet investments and any realised investment income (FY26 Results Announcement).

Products & Services

Real Estate

VehicleTypeDescriptionTarget investorLaunchFee model / HMC stake
HomeCo Daily Needs REIT (ASX: HDN)Listed A-REITConvenience, neighbourhood and large-format retail centres anchored by daily-needs tenantsRetail and institutionalNov 2020 IPOExternal management fees; HMC 10.5% (FY26 4E)
HealthCo Healthcare & Wellness REIT (ASX: HCW)Listed A-REITHospitals, aged care, childcare, life sciences and health precinctsRetail and institutional2,021External management fees; HMC 22.7% (FY26 4E)
Unlisted Healthcare Fund (UHF)Unlisted wholesaleHealthcare real estate including Healthscope-leased hospitalsInstitutional/wholesale~FY23–FY24Mgmt fees; 15% IRR since inception at 1H FY24
Last Mile Logistics (LML) Fund IUnlistedUrban infill logistics; ~$1.0bn fully deployed; ~$140m near-term development pipelineInstitutional/wholesale~FY23Mgmt fees; 23% IRR since inception at 1H FY24
HMC Australia Retail Partnership (HARP)Unlisted institutionalRetail/daily-needs strategy with institutional partner(s)Institutional2H FY25Mgmt fees
HMC Unlisted Grocery Fund (HUG)UnlistedGrocery-anchored assets; ~$1.2bn development programInstitutional/wholesale2H FY25Mgmt and development fees
Real estate development pipelineBalance sheet / funds~$1.4bn pipeline, including HDN development optionality—OngoingDevelopment fees

HARP and HUG were initially targeting up to $2bn of combined AUM (FY25 Results Presentation).

Private Credit

OfferingDescriptionTarget investorLaunchNotes
HMC Private Credit (ex-Payton Capital)Senior secured commercial real estate lendingWholesale and HNWAcquired 2024~$1.6bn AUM at acquisition
HMC Private Credit Core FundOpen-ended wholesale fundWholesaleCapital raising launched Aug 2025$100m Core Fund raise noted in FY25
Institutional mandates (incl. TPG Credit partnership)Separately managed CRE lending mandatesGlobal institutionsJune 2026~$1.35bn funding; ~$375m of seed loans at financial close; balance in FY27

FY26 platform AUM was ~$2.3bn, with a pipeline of more than $4bn under evaluation and more than $1bn of committed capital available (FY26 Remuneration Report).

Digital Infrastructure

Asset / vehicleDescriptionStatus
DigiCo Infrastructure REIT (ASX: DGT)Data centre owner/developer; HMC 20.7% stakeListed Dec 2024; strategy refocused on Australia in FY26
SYD1 (Sydney, ex-Global Switch)Hyperscale/enterprise facility <1km from the Sydney CBD; first 20MW expansion delivered; LOIs signed for the remaining 52MW; holds "Strategic Certification" under the Hosting Certification FrameworkExpansion fully funded across FY27–FY28
iseekAustralian co-location platform (seed asset)Retained
CHI1 (Chicago, Elk Grove Village)US enterprise/hyperscale data centreSale agreed at US$750m (~5% premium to Nov 2024 cost; 5.8% passing yield); ~A$360m net proceeds; close expected 1Q FY27
LAX1 / LAX2 (Los Angeles)Development land; book value ~US$71mBeing monetised; LAX1 application withdrawn
Dallas-Fort Worth, Kansas CityUS operating assetsRetained as core
StratCap (USA)US digital infrastructure funds manager acquired Sep 2024Discontinued operation; wind-up underway

Sources: DGT releases (6 May 2026), Reuters/DealStreetAsia, Mingtiandi, CoStar, FY26 Results.

Energy — Illuma Energy

Project / componentDescriptionStatus
Illuma Energy platformRenewable generation and storage developer/owner; HMC 80% economic interest, equity accounted, joint control with KKRKKR financial close 30 Jun 2026
Kentbruck Wind Farm (VIC)Up to ~600MW wind; approved; Capacity Investment Scheme commitmentsOff-take negotiations reported as advanced (RenewEconomy, Feb 2026)
Moorabool BESS (VIC)Up to ~600MW battery; Capacity Investment Scheme Agreement awardedFirst BESS FID; KKR to fund up to $248m
Neoen Victorian portfolioAcquired 1 Aug 2025 for ~$950mIntegrated
STOR-EnergyBattery developer; remaining equity acquiredIntegrated
Pipeline~5GW (FY26), described earlier as 5.7GW across 19 projects~2.3GW targeted for FID within 12–18 months of Feb 2026

HMC's remaining investment is approximately $200m. HMC has stated an IRR target above 20% and a ~4x money multiple over five years, and receives $5m p.a. for corporate services (FY26 Results; RenewEconomy; Kalkine).

Private Equity (discontinued)

VehicleDescriptionOutcome
HMC Capital Partners Fund I (HMCCP)Concentrated stakes in ASX/NZX-listed companies (e.g., Sigma Healthcare, Ingenia Communities, Baby Bunting, Lendlease)Returned 56.2% net in CY24 and 43.6% net in FY25; wound up June 2026; inception investors earned a ~17.5% IRR (Stocks Down Under)
HMC Capital Partners Retail Fund IRetail feederClosure announced 1 Apr 2025; proceeds distributed July 2025; wind-up completed 23 Apr 2026
HMCCP Fund IIProposed closed-end fund (Healthscope recapitalisation flagged as an opportunity)Not launched in practice (no subsequent capital-raising disclosure identified)

Financial Narrative

Important framing. HMC is an asset manager with a large principal investment book. Gross profit, EBITDA and gross margin are not reported in their conventional form. Statutory profit is dominated by fair value movements and equity-accounted results. Management's primary metrics have been Operating Earnings (OE) through FY26 and Underlying Earnings from FY27.

Income statement (chartable)

Sources and notes:

  • FY26 Appendix 4E and Financial Report; FY26 Remuneration Report Table 10 (OE cps, NPAT, DPS for FY21–FY26); FY24 Results and Quartr summary (FY24 revenue $189.5m, post-tax OE $115.0m); Australian Property Journal (FY24 FV gains $121.4m).

  • FY23 pre-tax OE is derived from the reported +57% growth to $129m.

  • FY21: OE pre-tax 13.1c, NPAT $(85.9)m.

  • FY26 underlying EPS (pre-tax, excluding Stratcap) was 30.2c, and OE excluding discontinued operations was 43.7c.

Margins (derived)

Gross margin and EBITDA margin are not meaningful or not disclosed for this business model. OE-based margins exceed "normal" levels because OE includes investment income that sits outside revenue.

Growth

Derived from Table 10 OE cps and reported AUM. FY26 AUM growth is calculated on a like-for-like basis against the restated FY25 base excluding Stratcap: $18.2bn → $18.6bn = +2.2%. Against the originally reported $18.7bn, the change is -0.5%. Revenue CAGR FY24–FY26 (incl. discontinued) is -0.3% p.a. (derived: 189.5 → 188.2). Operating EPS CAGR FY21–FY26 is 25.3% p.a. (13.1c → 40.4c, derived).

Balance sheet (chartable)

Notes:

  • FY24 cash and equity are from opening balances in the FY25/FY26 statements. FY24 attributable equity is derived (1,506.8 less NCI of 283.9).

  • Consolidated net debt is derived (borrowings less cash).

  • Corporate net debt is as stated by the company and excludes $105m of non-recourse fund facilities. FY25 corporate balance sheet was net cash, entered as 0.

  • Working capital is derived (current assets less current liabilities).

  • Group debt facility is $715m (upsized from $675m), with $176.6m drawn plus $42.9m of bank guarantees. Gearing is 10.7% and the weighted average cost of debt is 6.5%. The facility matures 26 November 2027.

Cash flow (chartable)

FCF is derived as OCF less PP&E capex. Commentary: OE-to-cash conversion has been weak because management fees were partly paid in scrip or deferred, and because investment income is largely non-cash. Management guides to 100% conversion of FY27 underlying earnings to cash as these non-cash fee arrangements end (FY26 Results Announcement).

Ratios (derived from statutory accounts)

n/m = not meaningful for an asset manager without inventory or a reported EBITDA. Management targets a 20% ROE through the cycle.

Trend commentary

FY22–FY24 (platform building). Operating EPS went from 30.3c (FY22) to 26.4c (FY23) and then 37.0c (FY24). The FY23 dip reflected weaker investment income in a rising-rate environment. FY24 benefited from management fee growth (+14% to $79.7m), an HMCCP revaluation and a $15.6m performance fee. AUM rose 30% to $12.7bn, helped by Payton and StratCap being counted in AUM.

FY25 (peak). Pre-tax OE rose 74% to $224.6m, driven by the DGT IPO (large transaction fees of $59.1m), the HMCCP performance fee ($24.7m) and strong principal investment gains, including Sigma Healthcare during its merger with Chemist Warehouse. Statutory NPAT more than doubled to $265.2m, including $117.9m attributable to NCI. A $300m equity raising and SPP lifted contributed equity by $335.5m.

FY26 (reset and simplification). OE fell 26% to $166.8m (40.4c) as FY25's one-off fees rolled off. Recurring FM revenue grew 22%, which supports management's claim that earnings quality improved. Statutory results swung to a $111.6m loss. The drivers were fair value losses of $133.3m, an associate loss of $51.1m (including $57.4m from Illuma), a $32m impairment and a $68.0m loss from discontinued Stratcap. Cash fell to $19.4m and drawn debt rose to $176.6m, so the corporate balance sheet moved from net cash to modest net debt of $158.1m. NTA per share fell 21% to $2.86.

Inflection to watch. FY27 guidance of ≥35c underlying EPS (+16%) relies on >30% recurring FM revenue growth, ~35% higher co-investment distributions and cost savings. FY27 is therefore the first year in which the "simplified HMC" can be tested against a cleaner earnings metric.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Per-Share Data

MetricFY22FY23FY24FY25FY26

Revenue incl. discontinued ops (AUD Mn)

——189.5234.2188.2

Revenue continuing ops, re-presented (AUD Mn)

———227.8181.9

Total revenue and other income ex-FV, continuing (AUD Mn)

———258.2232.4

Change in FV of assets/liabilities (AUD Mn)

——121.4269.7-133.3

Pre-tax operating earnings (AUD Mn)

—82.4129.3224.6166.8

Post-tax operating earnings (AUD Mn)

——115.0211.9199.4

Statutory profit before tax, continuing (AUD Mn)

———297.0-76.2

Statutory NPAT incl. NCI (AUD Mn)

107.383.3114.4265.2-111.6

NPAT attributable to owners (AUD Mn)

———147.3-49.1

Operating EPS pre-tax (AUD cents)

30.326.437.056.040.4

Basic EPS statutory (AUD cents)

———36.76-11.90

Diluted EPS statutory (AUD cents)

———36.51-11.90

Dividend per share (AUD cents)

12.012.012.012.012.0

Weighted average shares (M)

———400.8412.6

Margin Analysis (%)

MetricFY24FY25FY26

Pre-tax OE / revenue incl. discontinued (%)

68.295.988.6

Statutory NPAT incl. NCI / revenue (%)

60.4113.2-59.3

Operating margin as reported by company (%)

68——

Margin Analysis (%) (FY22–FY26)

MetricFY22FY23FY24FY25FY26

Operating EPS growth YoY (%)

131.3-12.940.251.4-27.9

AUM growth YoY (%)

——3047-0.5

Balance Sheet and Per-Share Data

MetricFY24FY25FY26

Total assets (AUD Mn)

—2,180.61,985.1

Cash and equivalents (AUD Mn)

186.6120.919.4

Borrowings current (AUD Mn)

—129.30

Borrowings non-current (AUD Mn)

—0280.6

Consolidated net debt (AUD Mn)

—8.4261.2

Corporate net debt per company (AUD Mn)

—0158.1

Total equity incl. NCI (AUD Mn)

1,506.81,881.41,541.8

Equity attributable to owners (AUD Mn)

1,222.91,658.91,541.8

Intangible assets incl. goodwill (AUD Mn)

—393.3360.8

Equity-accounted investments (AUD Mn)

—992.71,213.9

Working capital (AUD Mn)

—533.9161.3

NTA per share (AUD)

—3.612.86

NTA + undrawn debt (AUD Bn)

1.42.01.9

Cash Flow

MetricFY25FY26

Operating cash flow (AUD Mn)

31.0-22.6

Capex — PP&E (AUD Mn)

8.67.1

Free cash flow (AUD Mn)

22.4-29.7

Dividends paid to HMC shareholders (AUD Mn)

47.449.6

Share buybacks (AUD Mn)

00

Treasury share purchases (AUD Mn)

7.52.8

Proceeds from share issues (AUD Mn)

299.50

Distributions received from investments (AUD Mn)

45.454.1

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY25FY26

ROE — attributable NPAT / avg attributable equity (%)

10.2-3.1

ROE — pre-tax OE / avg attributable equity (%)

15.610.4

ROA — NPAT incl. NCI / avg total assets (%)

—-5.4

Current ratio (x)

3.422.56

Debt / equity (%)

6.918.2

Net debt / EBITDA

n/m

n/m

Interest coverage — (pre-tax OE + finance costs) / finance costs (x)

11.06.5

Asset turnover — revenue / avg assets (x)

—0.09

Cash conversion cycle

n/m

n/m

Revenue by Region

RegionFY24FY25FY26

Loss from discontinued operations, USA (AUD Mn)

0-19.1-68.0

Foreign currency translation OCI (AUD Mn)

—0.4-13.2

Share Price and Margin Analysis (%)

MetricFY22FY23FY24FY25FY26

Share price at 30 June (AUD)

4.515.067.215.102.97

Total shareholder return (%)

-14.312.845.4-24.9-34.0

Dividend per share (AUD cents)

12.012.012.012.012.0

Share Price & Returns

PeriodReturn / data point

All-time high

$13.16 (Nov 2024)

CY2025 price change

-59.4% ($9.75 → $3.96)

FY26 price change

-41.5% ($5.08 → $2.97)

1-year (to Jun 2026)

-41.7% (5.10 → 2.97, price only, derived)

3-year TSR (FY24–FY26)

-31% (FY26 Remuneration Report, LTI test)

5-year price (Jun 2021 → Jun 2026)

-45.4% price only (5.44 → 2.97, derived; excludes the HDN in-specie distribution and dividends)

2026 YTD range (to Aug)

Low $2.16, high $4.62

Last verified close

$3.15 (5 Aug 2026); +11% on 26 Aug 2026 results day

Valuation Snapshot

MultipleValueBasis

P / FY26 op EPS pre-tax (x)

7.8

40.4c

P / FY26 underlying EPS pre-tax (x)

10.4

30.2c

P / FY27 guided underlying EPS (x)

9.0

≥35c

Statutory P/E

n/m

Loss-making

P / book (x)

0.84

Book value $3.74 per share

P / NTA (x)

1.10

$2.86

EV / Sales (x)

7.7

EV ≈ $1.30bn market cap + $158.1m corporate net debt = ~$1.46bn; revenue $188.2m

EV / EBITDA

n/m

EBITDA not reported

FY26 dividend yield (%)

3.8

12c

FY27 guided dividend yield (%)

4.8

15c

Analyst Ratings & Targets

Broker / sourceRatingTarget (AUD)Date

Bell Potter

Buy

8.15

Late 2025 (Kalkine)

Bell Potter

Positive on FY26 result; expects further gains

—

Aug 2026 (Motley Fool)

Most recent rating per TipRanks

Buy

3.60

Mid-2026

UBS

Valuation reference 13.5x FY26e

—

Apr 2025

Market Matters

Holder (4% target weight)

—

Mid-2026

Debt Facilities

FacilityLimit (AUD Mn)Drawn incl. guarantees (AUD Mn)Maturity

Secured syndicated facility (incl. $50m bank guarantee facility)

715.0219.5

26 Nov 2027

Non-recourse facilities in consolidated private credit funds

105.0——

Analyst Conclusions

Management guidance (FY27)

Underlying EPS (pre-tax) of at least 35c, up 16%, and DPS of 15c, up 25%. The drivers are >30% recurring FM revenue growth (led by Digital and Private Credit), ~35% higher co-investment distributions from DGT, HCW and HDN, and cost efficiencies. Guidance excludes capital-recycling upside and realised investment income. Management expects 100% cash conversion.

Consensus growth

The ≥16% underlying EPS growth guidance is the most reliable anchor.

Bull case

  1. Earnings quality inflection. Recurring FM revenue grew 22% in FY26 and is guided to grow >30% in FY27. With non-cash fee arrangements ending, cash earnings could finally track reported earnings.

  2. Hidden asset value. The stock trades at ~0.84x book. Illuma retains a ~5GW pipeline with KKR funding the first BESS, and DGT's CHI1 sale at a premium to cost supports the credibility of carrying values.

  3. Institutional platform. The KKR and TPG Credit mandates show global capital is willing to partner with HMC. Private credit could reach ~$3.3bn of AUM, with a pipeline above $4bn.

Bear case

  1. Statutory reality. HMC lost $111.6m in FY26, NTA per share fell 21%, and operating cash flow was negative.

  2. Dependence on stressed listed vehicles. Fee and distribution growth assumes that HCW resolves Healthscope and that DGT executes SYD1. Both vehicles have been significant underperformers.

  3. Credibility deficit. Successive resets — the $50bn target, HMCCP structural changes then closure, the StratCap purchase then exit — mean execution must be demonstrated, not promised. The facility refinancing in late 2027 adds a timetable.

Catalysts and monitorables (next 12 months)

CatalystExpected timing
AGM and trading update~Nov 2026
CHI1 sale completion; LAX monetisation1Q–2Q FY27
Binding SYD1 52MW leases (conversion from LOIs)FY27
Moorabool BESS FID; Kentbruck offtakeFY27
Healthscope hospital re-leasing resolutionFY27
Deployment of the private credit mandates (~$1bn post-seed)FY27
1H FY27 result: tracking vs ≥35c underlying EPS~Feb 2027
Balance-sheet recycling ($1.4bn) and any capital managementFY27
Debt facility refinancing ahead of Nov 2027 maturity2H FY27
First AASB S2 climate disclosuresFY27 annual report

Analyst verdict

HMC Capital is in transition from an acquisitive, sponsor-led growth story to a simpler, recurring-fee asset manager. The share price has already priced in much of the damage from that transition. Between November 2024 and mid-2026 the stock fell from $13.16 to roughly $2–3. Over the same period the company recorded a $111.6m statutory loss, cut operating EPS from 56c to 40.4c, wrote down NTA per share to $2.86, and reversed three strategic bets: US digital infrastructure, the HMCCP fund structure and an unrestrained energy balance sheet.

Underneath the noise, the fee base looks sturdier than the headline numbers suggest. Fee-generating AUM grew 15% to $16.9bn and recurring FM revenue rose 22%. The company also brought in two credible global partners in KKR and TPG Credit. On management's FY27 guidance, the stock trades at about 9x underlying pre-tax earnings, roughly 0.84x book, with a forward yield near 5%. That is a modest multiple for an alternatives manager with founder alignment of about 10%.

The investment case depends on HMC delivering on its new, lower bar. The specific tests are converting SYD1's LOIs into binding leases, resolving the Healthscope hospitals, deploying the private credit mandates, and showing that cash earnings now match reported underlying earnings. Investors also need to watch related-party governance across the listed REITs and the refinancing due in November 2027.

On balance, HMC offers asymmetric but execution-dependent upside. Investors who are comfortable with key-person concentration and statutory volatility may find the discount to book and the FY27 growth guidance attractive. More cautious investors should probably wait for the 1H FY27 result to confirm the underlying earnings run-rate and cash conversion before concluding that the reset is complete.


Refresh the market price and analyst data before any investment use. This document is not investment advice.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenureBackground (paraphrased)

David Di Pilla

Managing Director & Group CEO; founder

Since 2016

20-year investment banking career, including 15+ years as Managing Director at UBS Investment Bank and earlier Vice President at JP Morgan; director of HDN, HCW and DGT; founder of Aurrum aged care

Will McMicking

Group CFO

Founding-era executive

Leads capital, finance, tax and IT; led FY26 debt extension and upsize

Victoria Hardie

Group COO (presented FY26 results); formerly Head of Private Equity

—

Led HMCCP and its wind-up

Andrew Selim

Group General Counsel & Company Secretary

Joined 2017

Formerly Senior Legal Counsel and Company Secretary at GPT Group; Senior Associate at Allens Linklaters

Chris Maher

Managing Director, Head of Digital Infrastructure; DGT interim CEO

DGT CEO since mid-2025

Stepped down from the DGT board in Oct 2025

Angela Karl

Managing Director, Head of Energy Transition (as of 1H FY25)

—

Current role post-Illuma n/d

Renee Jacob

Investor Relations

——

Sandra Francis

HR lead

Since 2022 (MarketScreener)

—

Directors' Remuneration

ExecutiveBase salaryCash bonusSuperShare-based (equity)Share-based (cash-settled)OtherTotal FY26Total FY25

David Di Pilla

1,060,395030,0002,632,64810,74069,6653,803,4483,035,240

Will McMicking

660,846325,13330,000370,4260-5,8991,380,5061,273,170

Board of Directors

DirectorRoleIndependentCommitteesBackground (paraphrased)Shares held (30 Jun 2026)FY26 total remuneration (AUD)

Chris Saxon

Chair (since 1 Jan 2021)

Yes

Chair, Remuneration & Nomination

Former Baker McKenzie partner; Chair of Baker McKenzie Australia 2012–2017; M&A and energy lawyer

345,724251,218

David Di Pilla

MD & CEO

No

— (attends by invitation)

See above

43,109,398

See 9.2

Greg Hayes

NED

No

Audit & Risk

Former CFO and Executive Director of Brambles; former CEO of Tenix; former director of Ingenia and HDN

11,216,711110,533

Kelly O'Dwyer

NED

Yes

Chair, Sustainability; Audit & Risk; Rem & Nom

Former federal Cabinet Minister; NED of EQT, HCW, DGT, Barrenjoey and the National Reconstruction Fund Corporation; joined the Magellan board 1 Jul 2026

133,113149,757

Susan Roberts

NED

Yes

Chair, Audit & Risk; Sustainability

Former CEO of Lazard Asset Management Pacific; actuary

88,314140,679

Dr Chris Roberts AO

NED (since 27 Nov 2024)

Yes

Audit & Risk; Rem & Nom

Former Cochlear CEO (2004–2015); NED of Sigma Healthcare, Clarity Pharmaceuticals and HCW

313,226123,961

Fiona Pak-Poy

NED (since 27 Nov 2024)

Yes

Sustainability

Chair of Tyro; former NED of WiseTech; HBS MBA

12,122113,623

Board & Management Changes

DateChange

27 Nov 2024

Zac Fried and Brendon Gale retire; Chris Roberts AO and Fiona Pak-Poy join

Nov 2024

Julia Gillard appointed Chair of the energy transition platform

Mid-2025

DGT: Damon Reid moves from CEO to COO; Chris Maher becomes CEO

10 Oct 2025

Chris Maher leaves the DGT board while remaining CEO; Michael Juniper joins the DGT board

FY26

No changes to the HMC Board or committees (FY26 Remuneration Report)

By Aug 2026

Victoria Hardie presents as Group COO

Major Shareholders

HolderShares% of 412.6M (derived)Source

David Di Pilla (and related parties)

43,109,39810.4

FY26 Directors' Report

Greg Hayes (and related parties)

11,216,7112.7

FY26 Directors' Report

Will McMicking

2,905,7430.7

FY26 Remuneration Report

All other directors combined

892,4990.2

FY26 Remuneration Report

Competitive Landscape

Competitors by Segment

VerticalNamed competitorsRelative positioning of HMC

Real estate funds management

Charter Hall Group, Dexus, Goodman Group, GPT Group (funds management), Centuria Capital, Vicinity Centres, Region Group (convenience retail), Lendlease Investment Management

Mid-sized; niche leadership in large-format and daily-needs retail via HDN; healthcare via HCW

Private credit (CRE)

Qualitas, Metrics Credit Partners, La Trobe Financial, MA Financial, Pallas Capital, Merricks Capital

Smaller than leaders; differentiated by real estate origination heritage

Digital infrastructure

NEXTDC, AirTrunk (Blackstone), CDC Data Centres, Macquarie Data Centres (Macquarie Technology), Equinix and Global Switch internationally

Small (SYD1-centric) but in a scarce CBD location

Energy transition

Squadron Energy, Tilt Renewables, Edify Energy, Akaysha Energy (BlackRock), Neoen (other states), ACEN Australia

Development-stage pipeline; KKR backing adds credibility

Diversified alternatives (listed peers)

Macquarie Asset Management, MA Financial Group, Charter Hall, Pinnacle Investment Management, GQG (listed equities)

HMC is the most "deal-sponsor"-style of the ASX alternatives managers

Peer Comparison FY2026

MetricHMC Capital FY26Charter HallQualitasMA Financial

AUM / FUM (AUD Bn)

18.6———

Revenue (AUD Mn)

188.2———

Earnings growth (%)

-27.9 (op EPS)

———

Margin (%)

88.6 (pre-tax OE / revenue)

———

R&D intensity (%)

0000

Recent Developments

--

Company Snapshot

70

Employees

2016

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Recurring fee growth: recurring FM revenue +22% to $165.5m in FY26.
  • Founder alignment: Di Pilla owns 43.1m shares (~10.4%) and bought ~$7m on market in Aug–Sep 2025.
  • Liquidity: $1.9bn of tangible assets plus undrawn debt; corporate gearing of only 10.7%.
  • Institutional validation: KKR committed up to $603m and private credit secured $1.35bn of mandates in FY26.
  • Permanent capital: three ASX-listed REITs (HDN, HCW, DGT) provide sticky fee bases.
  • Track record of large transactions: the Masters portfolio, Global Switch Australia SYD1 (~$1.94bn) and Neoen VIC (~$950m).
  • Listed-to-unlisted capability: unlisted real estate AUM +15% to $2.9bn.

Weaknesses

  • Earnings volatility: a statutory loss of $111.6m in FY26 after a $265.2m profit in FY25.
  • Weak cash conversion: operating cash flow of $(22.6)m in FY26 against $166.8m of pre-tax OE.
  • Target credibility: $50bn AUM ambition vs $18.6bn actual; HMCCP closed; US exit reverses the 2024 strategy.
  • TSR: -34.0% in FY26 and -24.9% in FY25; ranked last of 22 peers on the FY24 LTI measure.
  • NTA erosion: NTA per share fell from $3.61 to $2.86.
  • Related-party complexity: board interlocks across HMC, HDN, HCW and DGT; DGT lacks majority independence.
  • Below-target cost discipline: FM EBITDA of $74m vs the $85m target.

Opportunities

  • Private credit scaling: expected AUM of ~$3.3bn plus a pipeline above $4bn.
  • SYD1 lease-up: LOIs for 52MW, with the project fully funded.
  • Illuma Energy value realisation: ~5GW pipeline, with a >20% IRR and ~4x multiple targeted.
  • Capital recycling: $1.4bn of balance-sheet investments, excluded from guidance.
  • Real estate deployment: ~$2bn of medium-term opportunities, including the ~$1.2bn HUG development program.
  • Healthscope resolution: would allow HCW to restore distributions and fees (6.0c FY27 guidance, subject to resolution).
  • Index re-inclusion: possible if the market cap recovers.

Threats

  • Interest rates: multiple rate increases hurt 2H FY26 origination volumes.
  • Tenant failure: an unresolved Healthscope situation across 10 hospitals.
  • Weak REIT prices: DGT and HCW price weakness limits capital raising and fee growth.
  • Energy development risk: the $57.4m Illuma associate loss in FY26 shows the earnings drag before projects reach FID.
  • Private credit regulation: heightened ASIC focus on the sector (general industry risk).
  • Refinancing: the $715m facility matures 26 November 2027.
  • Key-person dependency: concentrated on the founder-CEO.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025HMCCP $300m interim distribution ($150m to HMC); retail feeder closure; Fund II flaggedCash crystallisation; start of PE strategy doubts
21 May 2025HMCCP drops closed-end conversion; hurdle raised to 9%Investor pushback on structure
2025 (H1 CY)Healthscope enters receivership/administrationMajor tenant risk for HCW/UHF; overhang on HMC
Mid-2025DGT CEO change (Reid to COO; Maher CEO)Execution concerns at DGT
1 Aug 2025Neoen Victorian portfolio acquisition completesEnergy platform scale; balance sheet usage
19 Aug 2025FY25 results: OE 56c; FY26 target ≥40cShares fell ~7% intraday; down 67% YTD (Capital Brief)
20 Aug – 5 Sep 2025Di Pilla buys ~$7m of shares on marketInsider conviction signal
Sep 2025Management steps back from the $50bn DGT AUM aspirationReset of ambitions (Kalkine)
30 Sep 2025FY25 final dividend 6.0c paid—
10 Oct 2025DGT board changesGovernance at a managed vehicle
Nov 2025AGM; LTI grants; O'Dwyer buys shares—
Dec 2025HMC removed from the S&P/ASX 200Passive selling; lower profile
Dec 2025Inaugural HMC and DGT Modern Slavery StatementsESG disclosure
6 Feb 2026KKR to invest up to $603m in the energy platformShares fell 2.7% (Kalkine); management later called the market reaction "harsh"
24 Feb 20261H FY26: op EPS 10.1c; NPAT $5.8m; AUM $19.5bn; 6.0c interimReaffirmed ≥40c target
Mar 2026DGT removed from the S&P/ASX 200Pressure on a key co-investment
Early 2026StratCap/DGT withdraw LAX1 49.5MW applicationUS retreat begins
9 Apr 2026Interim dividend paid (1.0c franked)—
23 Apr 2026HMCCP Retail Fund wind-up complete—
6 May 2026Restructure at Macquarie Conference; DGT CHI1 sale (US$750m)HMC +17%, DGT +23–25%
26 Jun 2026Regulatory approvals for HMC–KKR partnershipPathway to close
29 Jun 2026$1.35bn private credit mandatesExpected PC AUM ~$3.3bn
30 Jun 2026KKR financial close; Illuma deconsolidated; HMCCP wind-up completedBalance sheet reset
1 Jul 2026Kelly O'Dwyer joins the Magellan boardDirector time-commitment monitorable
26 Aug 2026FY26 results; FY27 guidance ≥35c underlying EPS, 15c DPSShares +11% (Motley Fool); Bell Potter positive
Aug 2026HCW reinstates FY27 distribution guidance of 6.0c, subject to Healthscope resolutionPartial de-risking
7 Oct 2026FY26 final dividend 6.0c (unfranked) paid—
Expected 1Q FY27CHI1 sale completionFunds SYD1

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Income Statement: Revenue & Gross Profit: Total revenue and other income ex-FV, continuing fell from AUD 258.2 Mn in FY2025 to AUD 232.4 Mn in FY2026.
HMC Capital Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2024FY2025FY2026
Total revenue and other income ex-FV, continuing—258.2232.4
Revenue incl. discontinued ops189.5234.2188.2
Revenue continuing ops, re-presented—227.8181.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.